This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Perlan Therapeutics, Inc.. Active years: 2010-2013.
Company Filing History:
Years Active: 2010-2013
Title: John Reno: Innovator in Humanized Antibodies
Introduction
John Reno is a prominent inventor based in San Diego, CA, known for his significant contributions to the field of biotechnology. He holds 2 patents that focus on humanized antibodies, which play a crucial role in medical research and therapeutic applications.
Latest Patents
Reno's latest patents involve humanized antibodies that bind to ICAM-1, a critical component in the study of pathogen infections. These antibodies include various sequences, such as SEQ ID NO:1 and 3 (HumA), SEQ ID NO:5 and 7 (HumB), and several others up to SEQ ID NO:35 (HumI). His work also provides subsequences of these antibodies capable of binding to an ICAM-1 epitope. Furthermore, he has developed methods for inhibiting pathogen infections, such as human rhinovirus (HRV), using these innovative humanized antibodies.
Career Highlights
John Reno is currently associated with Perlan Therapeutics, Inc., where he continues to advance his research in antibody technology. His work has the potential to impact various therapeutic areas, particularly in combating viral infections.
Collaborations
Reno collaborates with talented individuals in his field, including Fang Fang and Lori Kohlstaedt, who contribute to the innovative environment at Perlan Therapeutics, Inc.
Conclusion
John Reno's contributions to the development of humanized antibodies represent a significant advancement in biotechnology. His innovative work continues to pave the way for new therapeutic strategies in the fight against infectious diseases.